Page 131 - Genomic Medicine in Emerging Economies
P. 131

120   CHAPTER 6:  Neuropsy chiatric Genomics in Latin Americ a




                                Cristiano, E., Rojas, J., Romano, M., Frider, N., Machnicki, G., Giunta, D., Correale, J., 2013. The
                                   epidemiology of multiple sclerosis in Latin America and the Caribbean: a systematic re-
                                   view. Mult. Scler. 19 (7), 844–854. doi: 10.1177/1352458512462918.
                                Cruz-Fuentes, C.S., Benjet, C., Martínez-levy, G.A., Perez-Molina, A., Briones-Velasco, M., Suarez-
                                   Gonzalez, J., 2014. BDNF Met66 modulates the cumulative effect of psychosocial childhood
                                   adversities on major depression in adolescents. Brain Behav. 4 (2), 290–297. doi: 10.1002/
                                   brb3.220.
                                Cuartas Arias, J.M., Palacio Acosta, C.A., Valencia, J.G., Montoya, G.J., Arango Viana, J.C., Nieto,
                                   O.C., Ruiz-Linares, A., 2011. Exploring epistasis in candidate genes for antisocial personality
                                   disorder. Psychiatr. Genet. 21 (3), 115–124. doi: 10.1097/YPG.0b013e3283437175.
                                Cupertino, R.B., Schuch, J.B., Bandeira, C.E., da Silva, B.S., Rovaris, D.L., Kappel, D.B., Mota, N.R.,
                                   2017. Replicated association of Synaptotagmin (SYT1) with ADHD and its broader influence in
                                   externalizing behaviors. Eur. Neuropsychopharmacol.doi: 10.1016/j.euroneuro.2017.01.007.
                                da Silva, B.S., Rovaris, D.L., Schuch, J.B., Mota, N.R., Cupertino, R.B., Aroche, A.P., Bau, C.H.,
                                   2016. Effects of corticotropin-releasing hormone receptor 1 SNPs on major depressive disor-
                                   der are influenced by sex and smoking status. J. Affect Disord. 205, 282–288. doi: 10.1016/j.
                                   jad.2016.08.008.
                                da Silva, T.L., Pianca, T.G., Roman, T., Hutz, M.H., Faraone, S.V., Schmitz, M., Rohde, L.A., 2008.
                                   Adrenergic alpha2A receptor gene and response to methylphenidate in attention-deficit/hyper-
                                   activity disorder-predominantly inattentive type. J. Neural Transm. (Vienna) 115 (2), 341–345.
                                   doi: 10.1007/s00702-007-0835-0.
                                Dahdouh, A., Taleb, M., Blecha, L., Benyamina, A., 2016. Genetics and psychotic disorders: a fresh
                                   look at consanguinity. Eur. J. Med. Genet. 59 (2), 104–110. doi: 10.1016/j.ejmg.2015.12.010.
                                de Azeredo, L.A., Rovaris, D.L., Mota, N.R., Polina, E.R., Marques, F.Z., Contini, V., Bau, C.H.,
                                   2014. Further evidence for the association between a polymorphism in the promoter region
                                   of SLC6A3/DAT1 and ADHD: findings from a sample of adults. Eur. Arch. Psychiatry Clin.
                                   Neurosci. 264 (5), 401–408. doi: 10.1007/s00406-014-0486-8.
                                De Castro, M., Restrepo, C.M., 2015. Genetics and genomic medicine in Colombia. Mol. Genet.
                                   Genomic Med. 3 (2), 84–91. doi: 10.1002/mgg3.139.
                                Demyttenaere, K., Bruffaerts, R., Posada-Villa, J., Gasquet, I., Kovess, V., Lepine, J.P., Consortium,
                                   W.H.O. World Mental Health Survey, 2004. Prevalence, severity, and unmet need for treatment
                                   of mental disorders in the World Health Organization World Mental Health Surveys. JAMA
                                   291 (21), 2581–2590. doi: 10.1001/jama.291.21.2581.
                                Disease, G.B.D., Injury, Incidence, & Prevalence, Collaborators, 2016. Global, regional, and na-
                                   tional incidence, prevalence, and years lived with disability for 310 diseases and injuries 1990–
                                   2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388 (10053),
                                   1545–1602. doi: 10.1016/S0140-6736(16)31678-6.
                                Duque, A.F., Lopez, J.C., Benitez, B., Hernandez, H., Yunis, J.J., Fernandez, W., Arboleda, G., 2015.
                                   Analysis of the LRRK2 p.G2019S mutation in Colombian Parkinson’s Disease Patients. Co-
                                   lomb. Med. (Cali) 46 (3), 117–121.
                                Figueira, P., Malloy-Diniz, L., Campos, S.B., Miranda, D.M., Romano-Silva, M.A., De Marco, L.,
                                   Correa, H., 2010. An association study between the Val66Met polymorphism of the BDNF
                                   gene and postpartum depression. Arch. Womens Ment. Health 13 (3), 285–289. doi: 10.1007/
                                   s00737-010-0146-6.
                                Flint, J., Munafo, M.R., 2007. The endophenotype concept in psychiatric genetics. Psychol. Med. 37
                                   (2), 163–180. doi: 10.1017/S0033291706008750.
                                Fonseca, D.J., Mateus, H.E., Gálvez, J.M., Forero, D.A., Talero-Gutierrez, C., Velez-van-Meerbeke,
                                   A., 2015. Lack of association of polymorphisms in six candidate genes in colombian adhd
                                   patients. Ann. Neurosci. 22 (4), 217–221. doi: 10.5214/ans.0972.7531.220405.
   126   127   128   129   130   131   132   133   134   135   136